V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20213215 | 20079697 | 0 | 93.6 | Adjuvant (A) | 2018-08-22 | 2018-08-27 | Cape+Cisplatin+Trastuzumab Load | 02 | N | IMATINIB | 100611832 |
| 20213216 | 20079698 | 1.79 | 76.3 | Palliative (P) | null | 2019-02-23 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | TRIAL | 101744727 |
| 20213217 | 20079699 | null | 57.8 | Curative (C) | 2018-10-15 | 2018-11-12 | FLUOROURACIL + MITOMYCIN + RT | N | N | FLUOROURACIL + MITOMYCIN + RT | 101007956 |
| 20213218 | 20079700 | 1.67 | 116.4 | Palliative (P) | 2019-05-07 | 2019-05-13 | GO2 TRIAL | 1 | N | TRIAL | 100715645 |
| 20213219 | 20079701 | 1.65 | 68.8 | Palliative (P) | 2018-08-02 | 2018-08-02 | GO2 TRIAL | Y | N | TRIAL | 100928833 |
| 20213221 | 20079702 | 0 | 70.9 | null | 2017-07-12 | 2017-07-13 | Cape+Cisplatin+Trastuzumab Load | 02 | N | LANREOTIDE | 100292434 |
| 20213222 | 20079703 | 1.55 | 70 | Curative (C) | null | 2019-05-23 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | N | FLUOROURACIL + MITOMYCIN + RT | 101408916 |
| 20213223 | 20079704 | 1.78 | 78.5 | null | 2016-09-07 | 2016-09-08 | LANREOTIDE | 02 | null | LANREOTIDE | 101735061 |
| 20213224 | 20079705 | 1.57 | 61.4 | null | 2018-01-19 | 2018-02-15 | LANREOTIDE | 02 | null | LANREOTIDE | 100432909 |
| 20213225 | 20079706 | 1.75 | 100 | Palliative (P) | 2018-09-19 | 2018-09-26 | Cetuximab + FLUOROURACIL + FOLINIC ACID + IRINOTECAN | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100475097 |
| 20213226 | 20079707 | 1.58 | 52.8 | Palliative (P) | 2019-08-06 | 2019-08-06 | LANREOTIDE | 99 | N | LANREOTIDE | 100971889 |
| 20213227 | 20079708 | 1.67 | 66.8 | Palliative (P) | 2018-09-01 | 2018-09-14 | Cape+Cisplatin+Trastuzumab Load | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101727632 |
| 20213228 | 20079709 | 1.78 | 104.9 | Curative (C) | null | 2016-10-24 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | Y | FLUOROURACIL + MITOMYCIN + RT | 100165681 |
| 20213229 | 20079710 | 1.6 | null | Curative (C) | 2017-05-19 | 2017-05-19 | HCX | 02 | N | IMATINIB | 100538751 |
| 20213230 | 20079711 | 1.76 | 91 | Curative (C) | 2018-02-03 | 2018-03-03 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | Y | FLUOROURACIL + MITOMYCIN + RT | 101312890 |
| 20213232 | 20079712 | 1.83 | 0 | Palliative (P) | 2020-02-02 | 2020-02-02 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100853884 |
| 20213233 | 20079713 | 1.68 | 69.9 | Curative (C) | 2019-12-05 | 2019-12-06 | FLUOROURACIL + MITOMYCIN + RT | N | Y | FLUOROURACIL + MITOMYCIN + RT | 101580613 |
| 20213235 | 20079715 | 1.76 | null | Curative (C) | null | 2019-02-08 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | Y | FLUOROURACIL + MITOMYCIN + RT | 100002817 |
| 20213240 | 20079716 | 1.6 | 48 | Palliative (P) | 2018-11-02 | 2018-11-07 | HCX | 02 | N | TRIAL | 100334253 |
| 20213241 | 20079717 | 1.7 | 81.6 | Palliative (P) | 2017-02-14 | 2017-02-15 | Trial Unspecified | Y | N | TRIAL | 101326398 |
| 20213242 | 20079718 | 0 | 78 | Palliative (P) | 2017-09-27 | 2017-10-03 | LANREOTIDE | 02 | N | LANREOTIDE | 100862701 |
| 20213243 | 20079719 | null | 74.7 | null | 2018-10-24 | 2018-11-19 | LANREOTIDE | 02 | N | LANREOTIDE | 100033270 |
| 20213244 | 20079720 | 1.73 | 79.4 | Palliative (P) | 2016-09-29 | 2016-10-05 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100384163 |
| 20213245 | 20079721 | 1.7 | 74.05 | Palliative (P) | 2019-05-26 | 2019-06-09 | HCX (Cape + Cisp + Tras) - Load | 02 | N | TRIAL | 100365811 |
| 20213246 | 20079722 | 1.88 | null | Curative (C) | 2019-09-12 | 2019-09-28 | FLUOROURACIL + MITOMYCIN + RT | 02 | N | FLUOROURACIL + MITOMYCIN + RT | 100723077 |
| 20213247 | 20079723 | 1.64 | 56.4 | Palliative (P) | 2018-05-05 | 2018-05-21 | Cape+Cisplatin+Trastuzumab Load | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101503495 |
| 20213248 | 20079724 | 1.62 | 63 | Palliative (P) | 2018-09-30 | 2018-10-14 | Cape+Cisplatin+Trastuzumab Load | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100947410 |
| 20213249 | 20079725 | 1.7 | 95.8 | Palliative (P) | 2019-08-28 | 2019-09-05 | Cetuximab + FOLFIRI cycle1 | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100142290 |
| 20213250 | 20079726 | null | 97.5 | Curative (C) | 2018-05-17 | 2018-06-01 | HCX | 02 | N | IMATINIB | 100911644 |
| 20213251 | 20079727 | 1.6 | 57 | Curative (C) | 2017-09-25 | 2017-10-13 | FLUOROURACIL + MITOMYCIN + RT | 02 | N | FLUOROURACIL + MITOMYCIN + RT | 101309256 |
| 20213252 | 20079728 | 1.78 | 78 | Palliative (P) | 2019-12-10 | 2020-01-01 | Trial Unspecified | 1 | N | TRIAL | 100738639 |
| 20213253 | 20079729 | 1.66 | 81.39 | Palliative (P) | 2016-06-11 | 2016-06-11 | GO2 TRIAL | Y | N | TRIAL | 100232417 |
| 20213254 | 20079730 | 1.77 | 76.4 | Palliative (P) | 2018-01-05 | 2018-01-24 | Trial Unspecified | 1 | N | TRIAL | 100734963 |
| 20213255 | 20079731 | 1.76 | null | Curative (C) | 2018-09-14 | 2018-10-15 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | Y | FLUOROURACIL + MITOMYCIN + RT | 101059339 |
| 20213256 | 20079732 | 1.8 | 71.2 | Curative (C) | 2019-01-15 | 2019-02-02 | HCX (Cape + Cisp + Tras) - Load | 02 | N | FLUOROURACIL + MITOMYCIN + RT | 100060725 |
| 20213257 | 20079733 | 1.73 | 57.8 | Palliative (P) | null | 2019-12-10 | Cape+Cisplatin+Trastuzumab Load | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101070169 |
| 20213259 | 20079734 | 1.76 | 70.9 | Palliative (P) | 2018-04-18 | 2018-05-02 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100407823 |
| 20213260 | 20079735 | 1.7 | 66.3 | Palliative (P) | 2019-03-21 | 2019-04-16 | Cape+Cisplatin+Trastuzumab Load | 02 | N | TRIAL | 101361571 |
| 20213262 | 20079736 | 1.8 | 60.1 | null | 2018-11-20 | 2018-12-04 | HCX (Cape + Cisp + Tras) - Load | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101483607 |
| 20213264 | 20079737 | 1.63 | 51.05 | Curative (C) | 2019-07-14 | 2019-07-16 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | IMATINIB | 101060848 |
| 20213265 | 20079738 | 1.69 | 55.8 | Curative (C) | 2019-10-04 | 2019-11-07 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | Y | FLUOROURACIL + MITOMYCIN + RT | 100437351 |
| 20213266 | 20079739 | 1.6 | 61.4 | Palliative (P) | 2018-10-03 | 2018-10-10 | Cape+Cisplatin+Trastuzumab Load | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101794855 |
| 20213267 | 20079740 | 1.55 | 47.45 | Curative (C) | 2019-01-06 | 2019-01-23 | HCX (Cape + Cisp + Tras) - Main | 02 | Y | FLUOROURACIL + MITOMYCIN + RT | 100906290 |
| 20213268 | 20079741 | null | null | Palliative (P) | 2019-09-12 | 2019-09-15 | LANREOTIDE | N | N | LANREOTIDE | 101788632 |
| 20213270 | 20079742 | 1.73 | 67.5 | Neo-adjuvant (N) | 2019-09-25 | 2019-09-26 | Trial Unspecified | 1 | N | TRIAL | 100109983 |
| 20213271 | 20079743 | 1.6 | 0 | Palliative (P) | 2019-03-27 | 2019-04-23 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100602605 |
| 20213272 | 20079744 | 1.79 | 86 | Palliative (P) | 2017-11-27 | 2017-11-29 | Cape+Cisplatin+Trastuzumab Load | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100527908 |
| 20213273 | 20079745 | null | 80.6 | Disease modification (D) | 2018-12-07 | 2018-12-14 | LANREOTIDE | 99 | N | LANREOTIDE | 101851732 |
| 20213274 | 20079746 | 0 | 75.9 | null | 2018-11-03 | 2018-11-03 | LANREOTIDE | 02 | N | LANREOTIDE | 101335277 |
| 20213275 | 20079747 | 1.59 | 88.4 | Palliative (P) | 2017-11-06 | 2017-12-03 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101134008 |